RSIC Fundamental Portfolio Review

August 2002

 

 

Although the Fundamental Portfolio only started in earnest last year, the majority of purchases prior to that date were made for fundamental reasons. I have therefore included all purchases prior to the setting of the strategy to be for the fundamental portfolio except for Atlantic Caspian and Templeton Emerging Warrants. Parity is treated as having been in the Fundamental Portfolio until August 2001 when it was transferred to the Speculative one.

 

Richard W, 18 August 2002.

 

1         Summary

·         Overall performance during the last year has been poor, with a net loss of almost £500 over the year representing a loss of 14.8% measured using the Internal Rate of Return;

·         Despite this, however, the portfolio has outperformed the FTSE 100 by 4.1%;

·         Since the start of the club, all purchases made on grounds that would have qualified the share for the Fundamental Portfolio have shown a combined profit of 19.5%.

 

1.1        Performance Against Objectives

Objectives of the Strategy for the Fundamental Sub-portfolio are (not necessarily in priority order):-

a)      To achieve an average annual rate of return on investment across the portfolio that beats the FTSE 100

Met - beat the FTSE 100 although still produced a loss in absolute terms.

 

b)      To protect against significant losses and to increase market knowledge by diversification across sectors.

Met - during the year, the portfolio has held seven shares from six different sectors.

 


2         Transactions

 

2.1        Total Transaction History

The following purchases have taken place to date (current holdings valued at realisable value):

 

Company

Date Bought

Price

# Shares

Cost

Dividends

Date Sold

Sale / Current Price

Proceeds / Current Value

Gain / Loss (inc dividends)

Gain / Loss %

Science Systems

21/10/98

145.80

500

£1,027.34

£11.05

23/02/01

583.00

£2,892.40

£1,876.11

182.6%

ARM Holdings

20/01/99

72.80

700

£509.49

£0.00

16/03/01

308.20

£2,145.40

£1,635.91

321.1%

Workplace Technologies

18/05/99

170.10

450

£765.26

£2.70

05/10/99

228.00

£1,026.00

£263.44

34.4%

Total Systems

22/12/99

79.50

1000

£810.98

£0.00

08/06/00

90.00

£888.00

£77.02

9.5%

Parity[1]

29/12/99

338.75

289

£998.88

£19.00

17/08/01

44.00

£127.16

-£859.95

-86.1%

Cable & Wireless

12/01/00

950.25

80

£776.00

£25.20

21/01/02

296.34

£237.08

-£513.72

-66.2%

Tibbett & Britten

27/04/00

613.00

160

£997.70

£37.12

20/09/01

616.00

£973.60

£13.02

1.3%

Science Systems

03/05/00

540.00

53

£286.20

£0.41

23/02/01

583.00

£306.59

£20.80

7.3%

Delta

28/09/00

120.00

810

£988.86

£64.90

19/10/01

96.10

£766.41

-£157.55

-15.9%

Cable & Wireless

16/11/00

897.51

85

£788.69

£14.03

21/01/02

296.34

£251.89

-£522.77

-66.3%

Headlam

29/12/00

138.50

709

£998.88

£134.36

 

260.00

£1,831.40

£966.88

96.8%

Blick

16/05/01

224.80

437

£999.29

£63.37

18/06/02

180.80

£778.10

-£157.82

-15.8%

Logica

29/05/02

226.39

346

£799.23

£0.00

 

151.50

£512.19

-£287.04

-35.9%

Fulcrum Pharma

06/06/02

12.65

4625

£599.99

£0.00

 

10.25

£462.06

-£137.93

-23.0%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

£11,346.79

£372.14

 

 

£13,198.28

£2,216.40

19.5%

 

 


2.2        Last Twelve Months

During the previous twelve months the following purchases have taken place:

 

Company

Date Bought

Price

# Shares

Cost

Logica

29/05/02

226.39

346

£799.23

Fulcrum Pharma

06/06/02

12.65

4625

£599.99

 

 

 

Total

£1,399.22

 

The following sales have taken place:

 

Company

Date Sold

Sale Price

Proceeds

Gain / Loss (inc dividends)

Gain / Loss %

Tibbett & Britten

20/09/01

616.00

£973.60

£13.02

1.3%

Delta

19/10/01

96.10

£766.41

-£157.55

-15.9%

Cable & Wireless

21/01/02

296.34